Acute Effects of Moderate-Intensity Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention (SWIMCOG)
Acute Effects of Moderate-Intensity Freestyle Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention: A Randomized Controlled Trial
This randomized controlled trial aims to investigate the acute effects of a single session of moderate-intensity freestyle swimming exercise on cognitive performance in healthy young adults. Cognitive functions such as inhibitory control, selective attention, and cognitive flexibility are essential components of executive functioning and play an important role in academic, occupational, and daily activities.
A total of 60 healthy adults aged 18-35 years will be randomly assigned to either an exercise group or a control group. Participants in the exercise group will complete a 30-minute session of moderate-intensity freestyle swimming, while participants in the control group will undergo passive seated rest for the same duration.
Cognitive performance will be evaluated immediately before and after the intervention using the Eriksen Flanker Task and the Stroop Color-Word Test. These assessments measure reaction time, attention control, information processing speed, and inhibitory control.
The study is designed to determine whether a single bout of swimming exercise can produce immediate improvements in executive functions compared with passive rest. Findings from this research may contribute to a better understanding of the relationship between aerobic exercise and cognitive performance and may help inform exercise-based strategies for enhancing cognitive health and performance in healthy individuals.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Istanbul
-
Istanbul, Istanbul, Turquía (Türkiye), 34290
- Istanbul Rumeli University, Faculty of Sport Sciences
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Healthy adults aged 18 to 35 years.
- Normal or corrected-to-normal vision.
- Right-handed as determined by the Edinburgh Handedness Inventory.
- No history of neurological, psychiatric, or cardiovascular disorders.
- Engaging in structured exercise fewer than three times per week.
- Ability to safely participate in moderate-intensity swimming exercise.
- Provision of written informed consent.
Exclusion Criteria:
- Use of medications that may affect cognitive performance.
- Active musculoskeletal injury or pain limiting participation in exercise.
- Previous experience with the Eriksen Flanker Task or Stroop Color-Word Test.
- Contraindications to swimming exercise.
- Participation in vigorous physical activity within 24 hours before testing.
- Any medical condition considered unsafe for exercise participation by the investigators.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Participants assigned to the experimental group completed a single 30-minute session of moderate-intensity freestyle swimming exercise.
The exercise protocol included a 5-minute warm-up, 20 minutes of continuous swimming at moderate intensity (approximately 60-70% of age-predicted maximum heart rate), and a 5-minute cool-down period.
|
A single session of moderate-intensity freestyle swimming lasting 30 minutes.
The protocol consisted of a 5-minute warm-up, 20 minutes of continuous freestyle swimming performed at approximately 60-70% of age-predicted maximum heart rate, and a 5-minute cool-down.
Exercise intensity was monitored using ratings of perceived exertion and heart rate measurements.
|
|
Sin intervención: Control Group
Participants assigned to the control group remained seated at rest for 30 minutes in a quiet environment.
During this period, participants were instructed to avoid physical activity and cognitive stimulation.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Congruent Flanker Task Reaction Time
Periodo de tiempo: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during congruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Incongruent Flanker Task Reaction Time
Periodo de tiempo: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during incongruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Stroop Test Completion Time
Periodo de tiempo: Immediately before and immediately after the 30-minute intervention session
|
Total completion time across the Stroop Color-Word Test (TBAG Form), assessing inhibitory control, selective attention, and cognitive flexibility.
|
Immediately before and immediately after the 30-minute intervention session
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- IRU-2026
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .